GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
Move to increase affordability and accessibility for heart failure patients across the country
Subscribe To Our Newsletter & Stay Updated